A Study of Characterizing Cognitive Decline and Functional Cardiac Senescence in Healthy Korean Volunteers
This study has been completed.
Korea Institute of Oriental Medicine
Information provided by (Responsible Party):
Dal-Seok Oh, OMD, PhD, Korea Institute of Oriental Medicine
First received: May 1, 2012
Last updated: April 1, 2014
Last verified: April 2014
- Although aging process appears to be generally characterized, investigators have been paid much attention to the specific target molecules, which leads to discover the clinical markers of the senescence. The present study is to investigate the clinical and biological profile of cognitive decline and functional cardiac senescence in healthy middle aged and elderly Korean volunteers.
- This study was conducted as a cross-sectional, single-center, comparative clinical study.
- Each volunteer was given informed consent for checking cognition and cardiac function. Blood and urine samples were collected to analyze genome, proteome, and metabolome to assess cognition and cardiac function of its muscle enzymes.
Mild Cognitive Impairment
|Study Design:||Observational Model: Case-Only
Time Perspective: Cross-Sectional
|Official Title:||An Association Study of Characterizing Cognitive Decline and Functional Cardiac Senescence Profile Through the Association of Biomarkers and Clinical Outcomes in Healthy Middle Aged and Elderly Korean Volunteers|
Resource links provided by NLM:
Further study details as provided by Korea Institute of Oriental Medicine:
Biospecimen Retention: Samples With DNA
Samples for single nucleotide polymorphism, and for cardiac enzyme level detection
|Study Start Date:||November 2011|
|Study Completion Date:||March 2013|
|Primary Completion Date:||October 2012 (Final data collection date for primary outcome measure)|
- The protocol of this study was developed as the first assessment of the three to four series of clinical research on senescence.
- This design of the study is a non-interventional, single-center, single-visit design for investigating the cognitive decline and cardiac function including heart muscle enzyme activity, which have been considered one of the key points in aging process.
- Volunteers visit the study site during the screening period, informed consent for study participation and blood draw are given respectively, then, the eligibilities are met, participants visit the study site just once within two weeks.
The participants undergo the following five procedures for 2-3 hours; out-patient visit,
- additional demographic interview including covariate factors (depression status, marital status
- vital sign check
- the questionnaire for cognitive function
- blood draw for genomic, proteomic, and metabolomic analyses (10 milli Liter), urine collection (20 milli Liter)
- electrocardiogram (ECG), then they are discharged.
- Their safety follow-up is monitored in a week (± 1 day) by a phone-call from the study associates.
- To evaluate cognitive function, several cognitive batteries were used, 3MSE (Modified-Mini Mental State Examination), ADAS-cog (Alzheimer's Disease Assessment Scale-cognitive subscale); for cognitive biomarkers, Apolipoprotein E, Type-3 metabotropic glutamate receptors.
- To evaluate cardiac function including its enzyme activity: HRV (heart rate variability), CRP (c-reactive protein); Cardiac Troponin T.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01590706
|Korea, Republic of|
|Dunsan Oriental Hospital of Daejeon Univ.|
|Daejeon, Korea, Republic of, 302122|
Sponsors and Collaborators
Korea Institute of Oriental Medicine
|Study Director:||Miyoung Lee, PhD||Korea Institute of Oriental Medicine|